ReviewInvestigational new drugs2002

Targeting anti-apoptotic genes upregulated by androgen withdrawal using antisense oligonucleotides to enhance androgen- and chemo-sensitivity in prostate cancer.

Martin E Gleave et al.PubMed ↗Publisher ↗

No numbers read from the abstract.